<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Assertio Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Assertio Therapeutics, Inc.

    Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Arthur J. Higgins
    • FOUNDED
      1995
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    SI-BONE, Inc.

    SI-BONE, Inc.

    SI-BONE is a medical device company that has pioneered a proprietary minimally inv...

    SI-BONE is a medical device company that has pi...

    Filing Type:    PU
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    Pluton Biosciences, LLC

    Pluton Biosciences, LLC

    Nature is full of untapped potential. Microbes are a proven but underused resource...

    Nature is full of untapped potential. Microbes ...

    Amount Raised:    $98,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    MannKind Corporation

    MannKind Corporation

    At MannKind Corporation (NASDAQ: MNKD), we focus on the discovery, development and...

    At MannKind Corporation (NASDAQ: MNKD), we focu...

    Filing Type:    PU
    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused o...

    Mirum Pharmaceuticals Inc. is a clinical-stage ...

    Filing Type:    PU
    Catalyst Biosciences, Inc.

    Catalyst Biosciences, Inc.

    Catalyst is focused on developing novel medicines to address serious medical condi...

    Catalyst is focused on developing novel medicin...

    Filing Type:    PU
    Acorda Therapeutics, Inc.

    Acorda Therapeutics, Inc.

    Acorda Therapeutics is a biotechnology company focused on developing therapies tha...

    Acorda Therapeutics is a biotechnology company ...

    Filing Type:    PU
    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.